Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.

di Cynthia Guilbert, Matthew G Annis, Zhifeng Dong, Peter M Siegel, Wilson H Miller, Koren K Mann
Pubblicazione 2013-01-01